HighVista Strategies’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,733
| Closed | -$239K | – | 164 |
|
|
2025
Q1 | $239K | Hold |
8,733
| – | – | 0.09% | 143 |
|
|
2024
Q4 | $351K | Sell |
8,733
-4,010
| -31% | -$161K | 0.13% | 133 |
|
|
2024
Q3 | $603K | Buy |
+12,743
| New | +$603K | 0.21% | 112 |
|
|
2023
Q2 | – | Sell |
-25,530
| Closed | -$756K | – | 145 |
|
|
2023
Q1 | $756K | Buy |
+25,530
| New | +$756K | 0.62% | 54 |
|
|
2021
Q3 | – | Sell |
-18,587
| Closed | -$901K | – | 132 |
|
|
2021
Q2 | $901K | Buy |
18,587
+4,646
| +33% | +$225K | 0.64% | 27 |
|
|
2021
Q1 | $542K | Sell |
13,941
-3,176
| -19% | -$123K | 0.4% | 66 |
|
|
2020
Q4 | $1.06M | Buy |
+17,117
| New | +$1.06M | 0.68% | 24 |
|